Trial Profile
Maraviroc in HIV Acute INfection
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2018
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
- Indications HIV infections
- Focus Proof of concept; Therapeutic Use
- Acronyms MAIN
- 28 Jul 2011 New trial record